# Replace Glycemic Load and Satiety Study

> **NCT01516333** · PHASE1 · COMPLETED · sponsor: **Pennington Biomedical Research Center** · enrollment: 26 (actual)

## Conditions studied

- Glucose Blood
- Glycemic Index

## Interventions

- **OTHER:** High GL 107
- **OTHER:** Medium GL 76
- **OTHER:** Medium GL 68
- **OTHER:** Low GL 48

## Key facts

- **NCT ID:** NCT01516333
- **Lead sponsor:** Pennington Biomedical Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01516333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01516333, "Replace Glycemic Load and Satiety Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01516333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*